Playback speed
10 seconds
Rheumatic Disease Patients with COVID-19: Is Timing Important for Biosimilars Therapy? Are Multiple Antiphospholipid Antibodies Associated with COVID-19? What Are the Downsides of Using Anti-Cytokine Therapy?
By
RheumNow
FEATURING
John J. Cush
By
RheumNow
FEATURING
John J. Cush
54 views
September 10, 2020
Comments 0
Login to view comments.
Click here to Login